The members of our management team provide a depth of industry and operating experience that is fundamental to the success of BIMI.
Mr. Song was appointed as the Company’s CEO and President in October 2019. He previously served as both the president and director of Shenyang Langzi Investment Management Co., Ltd., which he has held since December 2012. From July 2008 to July 2013, he was the chief representative of German Varengold Bank in China. From October 1999 to May 2008, he was the executive director and president of Liaoning Jiachang Group. He also serves as a director of BIQI International Holdings Corp. Mr. Song graduated from Peking University with bachelor’s and master’s degrees in mathematics.
Ms. Baiqun Zhong has been engaged in the financial and accounting industry for more than 30 years. Since October 2020, Ms. Zhong has served as the CFO of the Company’s wholly-owned subsidiary Bimai Pharmaceutical (Chongqing) Co., Ltd. From October 2019 to October 2020, she was the CFO of the Company’s wholly-owned subsidiary, Chongqing Guanzan Technology Co., Ltd. From January 2009 to September 2019, Ms. Zhong was the Chief Accountant of Chongqing Yichen Trade Company, in charge of the company’s financial affairs. Ms. Zhong holds a bachelor’s degree in accounting from Chongqing Technology and Business University and a Chinese CPA license.
Mr. Wang has been the Company’s Chief Operating Officer since February 2020. He is supervising our retail pharmacy, wholesale pharmaceuticals and wholesale medical device segments a. From July 2014 to January 2020, he served as the Supervisor of Chongqing Guanzan Technology Co., Ltd. and the General Manager of Chongqing Shude Pharmaceutical Co., Ltd. From October 2004 to June 2014, he was the President of Sales, and later the President of National Sales at Fujian Hongcheng Bio-Medical Co., Ltd.. Mr. Wang graduated from Chongqing Pharmaceutical High Level Specialty School and holds an MBA degree from Chongqing Normal University.